A detailed history of Moneta Group Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 13,093 shares of AMGN stock, worth $3.46 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,093
Previous 12,370 5.84%
Holding current value
$3.46 Million
Previous $3.87 Million 9.13%
% of portfolio
0.05%
Previous 0.06%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $223,681 - $243,925
723 Added 5.84%
13,093 $4.22 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $264,326 - $321,225
1,006 Added 8.85%
12,370 $3.87 Million
Q1 2024

Aug 13, 2024

BUY
$268.87 - $324.56 $241,176 - $291,130
897 Added 8.57%
11,364 $3.23 Million
Q4 2023

Feb 15, 2024

BUY
$255.7 - $288.46 $114,042 - $128,653
446 Added 4.45%
10,467 $3.01 Million
Q3 2023

Nov 15, 2023

BUY
$218.65 - $271.46 $259,537 - $322,223
1,187 Added 13.44%
10,021 $2.69 Million
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $81,636 - $96,533
381 Added 4.51%
8,834 $1.96 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $32,287 - $39,353
-143 Reduced 1.66%
8,453 $2.04 Million
Q4 2022

Feb 16, 2023

SELL
$229.03 - $291.01 $1.73 Billion - $2.19 Billion
-7,533,470 Reduced 99.9%
7,541 $1.98 Million
Q4 2022

Feb 16, 2023

BUY
$229.03 - $291.01 $241,626 - $307,015
1,055 Added 13.99%
8,596 $2.26 Million
Q4 2022

Feb 15, 2023

BUY
$229.03 - $291.01 $1.73 Billion - $2.19 Billion
7,532,031 Added 83875.62%
7,541,011 $1.98 Billion
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $53,645 - $60,502
-239 Reduced 2.59%
8,980 $2.02 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $430,504 - $479,076
1,866 Added 25.38%
9,219 $2.24 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $236,592 - $261,733
-1,079 Reduced 12.8%
7,353 $1.78 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $224,535 - $256,960
1,129 Added 15.46%
8,432 $1.9 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $26,958 - $31,584
-127 Reduced 1.71%
7,303 $1.55 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $63,300 - $70,226
-271 Reduced 3.52%
7,430 $1.81 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $970,634 - $1.13 Million
4,374 Added 131.47%
7,701 $1.92 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $157,957 - $188,099
730 Added 28.11%
3,327 $765,000
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $58,193 - $64,715
-248 Reduced 8.72%
2,597 $660,000
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $109,982 - $134,963
556 Added 24.29%
2,845 $671,000
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $146,885 - $194,810
-806 Reduced 26.04%
2,289 $464,000
Q4 2019

Feb 11, 2020

SELL
$189.21 - $243.2 $13,812 - $17,753
-73 Reduced 2.3%
3,095 $746,000
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $51,710 - $61,960
297 Added 10.34%
3,168 $613,000
Q2 2019

Aug 16, 2019

SELL
$166.7 - $195.41 $10.5 Million - $12.3 Million
-63,152 Reduced 95.65%
2,871 $529,000
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $10.5 Million - $12.3 Million
63,107 Added 2164.16%
66,023 $529,000
Q1 2019

May 16, 2019

SELL
$180.87 - $203.88 $118,108 - $133,133
-653 Reduced 18.3%
2,916 $554,000
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $5,426 - $6,116
30 Added 0.85%
3,569 $554,000
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $24,976 - $29,155
-140 Reduced 3.81%
3,539 $689,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $825,281 - $930,396
-4,454 Reduced 54.76%
3,679 $763,000
Q2 2018

Aug 15, 2018

SELL
$166.05 - $186.51 $4.8 Million - $5.39 Million
-28,907 Reduced 78.04%
8,133 $1.5 Million
Q2 2018

Aug 15, 2018

BUY
$166.05 - $186.51 $68,080 - $76,469
410 Added 1.12%
37,040 $1.5 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $5.99 Million - $6.72 Million
36,050 Added 6215.52%
36,630 $1.51 Million
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $84,037 - $98,208
496 Added 590.48%
580 $99,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $14,178 - $15,841
84
84 $15,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.